Q2 FY27 revenue up 49.7%; management expects higher margins and capacity use
FAIRCHEMOR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.3 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Q2 FY27 revenue rose 49.7% year on year to Rs 167 crore, with a 10.5% EBITDA margin and Rs 10.2 crore net profit. H1 revenue was Rs 343 crore, up 41.4%, with Rs 35.4 crore EBITDA and Rs 21.2 crore net profit. Management expects better input supply after soybean oil import duty fell to 11%, higher capacity use and an import-substitute product in Q3. Capacity use is 60-65%; no margin benefit was quantified, but management aspires to 15-18% EBITDA margins.
Cheaper inputs and better capacity use support earnings, but the 15-18% margin goal is aspirational; export and European cosmetics risks remain.